Researchers at Egypt’ s Assiut Grounds are studying the application of stem cell treatment for ailment diabetic foot ulcers. The interventional study, which is not so far open for enrollment, is an open-label single group selection.

Diabetic Ankle Ulcers and Amputations

It is estimated that approximately 15 percent of diabetics generate a foot ulcer at some point during the course of their disease. In the United States, diabetic is the primary cause of non-traumatic amputations of the lower vulnerable parts. About 60 percent of diabetics have peripheral damaged nerves which results in loss of protective sensation. Diabetics are also prone to atherosclerotic changes in the peripheral arteries. Combined with the anatomy of the foot combined with mechanical stresses it is subject to, these conditions predispose people suffering from diabetes to chronic foot ulcers.

Diabetic foot wounds are staged according to the comfort zone of soft tissue and bony involvement. The traditional techniques for diabetic foot ulcers are offloading the path, therapeutic footwear, debridement, antibiotic therapy, and saline dressings to keep the wound moist. Peripheral arterial insufficiency can be addressed and blood glucose levels are controlled.

Unfortunately, foot ulcers are a significant complication of diabetes that tend to become chronic non-healing wounds. If a person with diabetes develops one ulcer, the chances of developing yet another ulcer are more. Despite advances in wound care in the last few decades, the outcomes for diabetic foot wounds never have changed substantially. This underscores the need to develop more effective complementary treatments for patients with diabetic foot ulcers.

Stem Cell Therapy for Diabetic Toes Ulcers

Stem cell therapy has proven great promise in wound healing and tissue reconstruction. One population of stem cells known as mesenchymal leaves cells (MSCs) are multipotent with several clinical practices. MSCs are particularly effective in differentiating into cells provided by the fascia. They are a source of soluble growth causes necessary for tissue regeneration and wound healing. MSCs exist in abundant quantities in adipose (fat) tissue. Actually , adipose-derived pluripotent stem cells are known to secrete constituents essential for healing damaged tissue. Moreover, adipose tissue can be purchased in plenty, can be isolated with ease, proliferates extensively ex-vivo, and thus secretes growth factors that promote angiogenesis (blood reef fishing boat formation). This makes adipose-derived mesenchymal stem cells an ideal extent therapy for chronic non-healing diabetic foot ulcers. Scientists are trying to develop strategies to ensure the viability and efficaciousness of MSCs in the hostile environment of ischemic cells.

New Research into Diabetic And also Wounds

The team at Assiut University or is investigating whether a curcumin-loaded chitosan scaffold will be within stem cell therapy for ischemic foot wounds. Curcumin is a substance found in turmeric, a traditional Indian spice for powerful medicinal properties. Chitosan is a type of fiber also found in crustacean shells. The question is whether this novel biocompatible and also biodegradable scaffold will increase regenerative efficiency in ischemic damage. The investigators will measure outcomes such as complete dealing with (full epithelization) of chronic diabetic foot wounds plant life percentage of patients who achieve 50 percent wound settlement in a period of six months. The rate of recurrence of ulcers after one year will also be reported. Approximately 40 patients through diabetes are expected to be enrolled in the study in October 2017 and the study will be completed in mid-2018.

Work references:


Mira Swave, MD

Contributor over Regenerative Medicine Now

Mira Swave, M. D. is a proeffieceint in the field of Regenerative Medicine.

Share the knowledge